SCHEMBL6236033

SCHEMBL6236033

COc1ccc(S(=O)(=O)N(c2ccccc2)C2CCCCC2)cc1N1CCNCC1

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 19/20 0.52
ESR1 P03372 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6236246 0.86 HTR6 (0.53) HTR6
SCHEMBL6234522 0.85 HTR6 (0.52) HTR6
SCHEMBL6188876 0.84 HTR6 (0.58) HTR6
SCHEMBL6235201 0.84 HTR6 (0.52) HTR6
SCHEMBL6234497 0.83 TSHR (0.65) HTR6
SCHEMBL32672558 0.79 HTR6 (0.58) HTR6
SCHEMBL32672532 0.77 HTR6 (0.59) HTR6
SCHEMBL4659557 0.77 HTR6 (0.62) HTR6
SCHEMBL6234462 0.76 PDE4A (0.62) HTR6
SCHEMBL6235673 0.76 PDE4A (0.62) HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1049679-B1 SULPHONAMIDE DERIVATIVES FOR TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 2005-06-01 EP claimed
US-6548504-B1 Compounds SMITHKLINE BEECHAM P.L.C. (GB) 2003-04-15 US claimed
EP-1049679-A2 SULPHONAMIDE DERIVATIVES FOR TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 2000-11-08 EP claimed
WO-1999037623-A2 SULPHONAMIDE DERIVATIVES FOR TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 1999-07-29 WO claimed
EP-1049679-B1 SULPHONAMIDE DERIVATIVES FOR TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 2005-06-01 EP disclosed
US-6548504-B1 Compounds SMITHKLINE BEECHAM P.L.C. (GB) 2003-04-15 US disclosed